SET7/9 Antibodies

Santa Cruz Biotechnology delivers a wide array of SET7/9 monoclonal antibodies for advanced research in the field of epigenetics. SET7/9 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SET7/9, also known as SETD7, is a lysine methyltransferase that plays a crucial role in the regulation of gene expression through histone modification. SET7/9 influences various cellular processes, including transcriptional regulation, DNA damage response, and cell differentiation. The significant role of SET7/9 in cellular processes makes it a promising therapeutic target in cancer and other diseases. Researchers worldwide rely on SET7/9 monoclonal antibodies to advance their understanding of epigenetic regulation mechanisms. SET7/9 monoclonal antibodies enable detailed investigation of methylation patterns and their effects on gene expression. Santa Cruz Biotechnology monoclonal antibodies support researchers in their mission to uncover new insights in epigenetics research and potential therapeutic applications.